Disbrow Jarrett 4
4 · AYTU BIOPHARMA, INC · Filed Jun 10, 2025
Insider Transaction Report
Form 4
Disbrow Jarrett
Chief Business Officer
Transactions
- Purchase
Common Stock
2025-06-09$1.50/sh+16,666$24,999→ 29,462 total
Footnotes (2)
- [F1]Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.
- [F2]Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.